The markets closed higher on Monday with BSE Sensex reclaiming the crucial 26,000 mark while the Nifty50 closing above its psychological mark of 7,900.
Meanwhile, investors will remain cautious ahead of F&O expiry of the December series, scheduled for December 31, 2015.
Also Read
Gold struggled to recover from overnight losses as a continuous slide in oil prices dented demand for the yellow metal.
Meanwhile, Foreign Institutional Investors (FIIs) were net sellers to the tune of Rs 302.62 crore on Monday as per provisional stock exchange data.
GLOBAL MARKETS
The Asian markets are trading mixed as crude oil prices resume their downward journey. Shanghai Composite is 0.2% lower while HangSeng is 0.1% higher. Nikkei is trading flat.
The slide in crude oil prices weighed on the energy shares on Wall Street thus dragging the US equities to close lower.
STOCKS TO WATCH
Oil Marketing Companies (OMCs): The three government oil marketing companies (OMCs) - Indian Oil Corporation (IOC), Bharat Petroleum Corporation (BPCL), and Hindustan Petroleum Corporation (HPCL) - might jointly set up a mega refinery at Ratnagiri in coastal Maharashtra.
Bharti Airtel: Bharti Airtel has launched a special website www.airtel.in/leap which will allow its customers to see the updates related to Project Leap - Rs 60,000 crore network transformation program on the site.
Infosys: Infosys will formally inaugurate its new campus at Pocharam here in February, according to chief executive officer and managing director Vishal Sikka.
SpiceJet: SpiceJet on Monday announced a four-day sale, offering one-way base fares as low as Rs 716 for the journey period between January 15 and April 12 next year for domestic fliers. Special fares under a “Happy New Year Sale” are available for flying on domestic routes, SpiceJet said
L&T Infotech: L&T Infotech is looking to raise over Rs 2,000 crore through IPO in the fourth quarter of the current fiscal to fund its expansion plans.
Lupin: Drug major Lupin has received US health regulator's approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)